HK1252937A1 - 用於治療抑鬱症的方法和試劑盒 - Google Patents

用於治療抑鬱症的方法和試劑盒

Info

Publication number
HK1252937A1
HK1252937A1 HK18112292.0A HK18112292A HK1252937A1 HK 1252937 A1 HK1252937 A1 HK 1252937A1 HK 18112292 A HK18112292 A HK 18112292A HK 1252937 A1 HK1252937 A1 HK 1252937A1
Authority
HK
Hong Kong
Prior art keywords
kits
methods
treating depression
depression
treating
Prior art date
Application number
HK18112292.0A
Other languages
English (en)
Inventor
Ivo Caers
Ella Daly
Wayne C Drevets
Jaskaran Singh
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1252937A1 publication Critical patent/HK1252937A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
HK18112292.0A 2015-05-20 2018-09-26 用於治療抑鬱症的方法和試劑盒 HK1252937A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562164026P 2015-05-20 2015-05-20

Publications (1)

Publication Number Publication Date
HK1252937A1 true HK1252937A1 (zh) 2019-06-06

Family

ID=57320901

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18112292.0A HK1252937A1 (zh) 2015-05-20 2018-09-26 用於治療抑鬱症的方法和試劑盒

Country Status (20)

Country Link
US (1) US20160338977A1 (zh)
EP (1) EP3297618A4 (zh)
JP (1) JP2018515557A (zh)
KR (1) KR20180008634A (zh)
CN (1) CN107735081A (zh)
AU (3) AU2016263598A1 (zh)
CA (1) CA2986477A1 (zh)
CL (1) CL2017002904A1 (zh)
CO (1) CO2017011564A2 (zh)
DO (1) DOP2017000268A (zh)
EA (1) EA201792545A1 (zh)
EC (1) ECSP17077930A (zh)
GT (1) GT201700246A (zh)
HK (1) HK1252937A1 (zh)
IL (1) IL255463A (zh)
MA (1) MA42135A (zh)
MX (1) MX2017014797A (zh)
PE (1) PE20180260A1 (zh)
PH (1) PH12017502103A1 (zh)
WO (1) WO2016187491A1 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201802104QA (en) 2013-03-15 2018-05-30 Janssen Pharmaceutica Nv Pharmaceutical composition of s-ketamine hydrochloride
US10098854B2 (en) 2014-08-13 2018-10-16 Janssen Pharmaceutica Nv Method for the treatment of depression
CA2961208A1 (en) 2014-09-15 2016-03-24 Janssen Pharmaceutica Nv Val66met (snp rs6265) genotype specific dosing regimens and methods for the treatment of depression
US20160332962A1 (en) 2015-05-13 2016-11-17 Janssen Pharmaceutica Nv (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
CA2987909C (en) 2015-06-27 2022-04-26 Shenox Pharmaceuticals, Llc Ketamine transdermal delivery system
US20200009081A1 (en) 2017-09-13 2020-01-09 Janssen Pharmaceutica N.V. Delivery Of Esketamine For The Treatment Of Depression
KR20240011237A (ko) * 2017-12-22 2024-01-25 얀센 파마슈티카 엔브이 우울증 치료를 위한 에스케타민
CA3103440A1 (en) * 2018-06-27 2020-01-02 Clexio Biosciences Ltd. Method of treating major depressive disorder
EP3628313A1 (en) * 2018-09-28 2020-04-01 Celon Pharma S.A. Ketamine composition for use in a method of treatment of depression by pulmonary administration
JP2022504036A (ja) 2018-10-05 2022-01-13 クレキシオ バイオサイエンシーズ エルティーディー． 大うつ病性障害を治療するためのエスケタミンの投与計画
WO2020070547A1 (en) * 2018-10-05 2020-04-09 Clexio Biosciences Ltd. Dosage regime of esketamine for treating major depressive disorder
WO2020070706A1 (en) * 2018-10-05 2020-04-09 Clexio Biosciences Ltd. Dosage regime of esketamine for treating major depressive disorder
US20210378989A1 (en) * 2018-10-11 2021-12-09 Clexio Biosciences Ltd. Esketamine for use in treating major depressive disorder
CA3131929A1 (en) * 2019-03-05 2020-09-10 Janssen Pharmaceuticals, Inc. Esketamine for the treatment of depression
JP2022546456A (ja) * 2019-08-28 2022-11-04 ヤンセン ファーマシューティカルズ，インコーポレーテッド 自殺傾向を含む大うつ病性障害を有する患者の治療のためのエスケタミン
TW202135787A (zh) 2019-12-12 2021-10-01 比利時商健生藥品公司 艾***調配物及製備與儲存的方法
GB202019952D0 (en) * 2020-12-17 2021-02-03 Neurocentrx Pharma Ltd Novel compositions
WO2022235576A1 (en) * 2021-05-03 2022-11-10 Wang Michael Z Methods and compositions for treating depression

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009530385A (ja) * 2006-03-22 2009-08-27 マウント シナイ スクール オブ メディシン うつ病の治療のためのケタミンの鼻内投与
PE20141906A1 (es) * 2012-03-12 2014-12-05 Janssen Pharmaceutica Nv Esketamina para el tratamiento de la depresion refractaria al tratamiento o resistente al tratamiento
KR20220044380A (ko) * 2013-04-12 2022-04-07 이칸 스쿨 오브 메디슨 엣 마운트 시나이 외상후 스트레스 장애의 치료 방법
CA2961208A1 (en) * 2014-09-15 2016-03-24 Janssen Pharmaceutica Nv Val66met (snp rs6265) genotype specific dosing regimens and methods for the treatment of depression

Also Published As

Publication number Publication date
MX2017014797A (es) 2018-02-15
EP3297618A4 (en) 2019-01-23
PE20180260A1 (es) 2018-02-05
CN107735081A (zh) 2018-02-23
AU2016263598A8 (en) 2017-11-30
AU2023237026A1 (en) 2023-10-12
PH12017502103A1 (en) 2018-05-07
CA2986477A1 (en) 2016-11-24
CL2017002904A1 (es) 2018-04-20
EA201792545A1 (ru) 2018-05-31
EP3297618A1 (en) 2018-03-28
WO2016187491A1 (en) 2016-11-24
KR20180008634A (ko) 2018-01-24
US20160338977A1 (en) 2016-11-24
CO2017011564A2 (es) 2018-04-19
DOP2017000268A (es) 2018-04-15
AU2021215155A1 (en) 2021-09-02
JP2018515557A (ja) 2018-06-14
ECSP17077930A (es) 2018-02-28
AU2016263598A1 (en) 2017-11-23
IL255463A (en) 2018-01-31
MA42135A (fr) 2018-03-28
GT201700246A (es) 2019-07-29

Similar Documents

Publication Publication Date Title
HK1252937A1 (zh) 用於治療抑鬱症的方法和試劑盒
IL259837A (en) Microfluidic devices and kits and their uses
IL260525B (en) Means and methods for treating the hepatitis virus (hbv)
EP3500289A4 (en) METHODS OF TREATING TRACHEOBRONCHOMALACIA
IL248803A0 (en) Means and methods for treating cmv
IL251759A0 (en) Preparations and methods for treating insomnia
ZA201906236B (en) Kits and methods for treating hair
HK1244217A1 (zh) 用於治療蛋白質病的方法
GB201514381D0 (en) Kit and Method
HK1247251A1 (zh) 用於增強的cgh分析的方法、載體和試劑盒
ZA201703771B (en) Compositions and methods for treating hyperkalemia
GB201700116D0 (en) Method and composition
GB201417372D0 (en) Methods and kits
EP3226691A4 (en) Composition and method for treating nematodes
EP3230308A4 (en) Methods for treating and preventing cardiomyopathy
SG10201505838PA (en) Method and kit
IL247379A0 (en) A method for treating depression and major depressive disorder
EP3215180A4 (en) Methods and kits for treating cardiovascular diseases
ZA201906319B (en) Methods of treating depression
GB201603567D0 (en) Method and kits
GB201509908D0 (en) Methods and kits
SG11201804140PA (en) Acidic-gas treating agent and acidic-gas treating method
GB201611189D0 (en) Method and composition
GB201421904D0 (en) Methods and kits
GB201601185D0 (en) Method and composition